Provided by Tiger Fintech (Singapore) Pte. Ltd.

CUTIA-B

6.200
-0.450-6.77%
Volume:1.10M
Turnover:6.93M
Market Cap:1.98B
PE:-4.09
High:6.740
Open:6.740
Low:6.140
Close:6.650
Loading ...

Company Profile

Company Name:
CUTIA-B
Exchange:
SEHK
Establishment Date:
2019
Employees:
333
Office Location:
Huanzhi Building,20th Floor,436 Heng Feng Road,Jingan District,Shanghai,China
Zip Code:
200070
Fax:
- -
Introduction:
Cutia Therapeutics is a China-based company mainly engaged in the research and development and manufacture of dermatological biological drugs. The Company is committed to developing comprehensive solutions to meet the diverse needs of patients and consumers in a wide range of dermatological treatment and care markets. The Company is mainly engaged in clinical trials of its core product CU-20401. This product is mainly used to treat submental fat accumulation. The Company conducts its businesses in the domestic market and overseas markets.